Answers are grounded in this paper and cite their sources.
Background. A practical antimicrobial catheter lock solution should have a wide safety margin, broad and rapid antimicrobial properties, and should not induce microbial resistance. Methods. A solution of 0.05% methylene blue (MB) and 7% sodium citrate at pH 6.2 with a preservative was tested against gram positive and gram negative bacteria and fungi from hospital isolates and ATCC. Some of the tested organisms were: E. coli, P. aeruginosa, E. feacalis, S. aureus (also MRSA), S. epidermidis, C. albicans, A. niger, and the halophilic bacterium V. vulnificus. The initial concentration of challenge suspensions was >106 CFU/mL bacteria, or >104 CFU/mL fungi. A study was also performed to evaluate the anti-biofilm properties of lock solution. The challenge organism was S. aureus (clinical isolate) perfused in plasma over polycarbonate strips alternating with lock solution. Results. For most tested strains a 99.99% reduction was obtained after 2 minutes of exposure to antibacterial solution, and in others this reduction was obtained in less than 1 hour. In control saline solution, concentration of microorganisms remained unchanged for 3 days. Studies of various components demonstrated synergistic rather than additive effects. The lock solution reduces CFU in biofilm from 105 CFU/mL to zero, even after repeated exposure to S. aureus in plasma. Conclusion. MB/citrate solution is microbicidal against all organisms tested. A randomized prospective multi-center trial is now beginning to compare CRBSI in CVC for dialysis, comparing the lock solution and heparin.
No takes yet. Share an insight, caveat, or question.
Ash et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: